Weight Loss Injections UK from £135.00 | Cured Pharmacy
Prescription Weight Loss Injections - Order Online
Takes less than 2 minutes to complete 100% online
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
Mounjaro Weight Loss Injections (Tirzepatide) KwikPen
Wegovy (Semaglutide) Weight Loss Injection
Wegovy® Oral Tablets (Semaglutide Pill): PRE-ORDER
Published on: June 03, 2026
Accessing prescription weight loss injections UK online has never been more straightforward for eligible patients. At Cured Pharmacy, our UK-registered clinical team provides free consultations for licensed treatments including Mounjaro, Wegovy, and Saxenda, with transparent pricing from £135.00 and discreet next-day delivery across the UK.
Understanding GLP-1 and Dual-Agonist Weight Loss Injections
Prescription weight loss injections work by mimicking natural gut hormones that regulate appetite and blood sugar control. GLP-1 receptor agonists like semaglutide (Wegovy) and liraglutide (Saxenda) have been licensed by the MHRA for weight management in adults with a BMI of 30 or above, or 27 with weight-related health conditions [1].
Tirzepatide (Mounjaro) represents the latest advancement as the UK's first dual GIP/GLP-1 receptor agonist. By activating two hormone pathways simultaneously, clinical trials demonstrated average weight reductions of up to 22.5% over 72 weeks in the SURPASS-3 study — significantly higher than single-pathway treatments [2]. These medications don't simply suppress appetite; they work with your body's natural satiety signals to reduce hunger and improve metabolic function.
All prescription weight loss injections available through Cured Pharmacy require clinical assessment by a UK prescriber. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every treatment is dispensed in accordance with MHRA guidelines and current NICE recommendations for weight management.
Mounjaro (Tirzepatide): The Dual-Agonist Breakthrough
Mounjaro comes as a pre-filled KwikPen for once-weekly subcutaneous injection. At Cured Pharmacy, genuine UK-licensed Mounjaro is available with transparent upfront pricing, subject to prescriber approval following your free online consultation. The treatment requires ongoing clinical monitoring, and our team provides continuous support throughout your weight management journey.
Clinical Evidence and Efficacy
The SURMOUNT-1 trial enrolled over 2,500 adults with obesity and demonstrated that tirzepatide produced dose-dependent weight loss, with the 15mg dose achieving an average reduction of 20.9% body weight compared to 3.1% with placebo over 72 weeks [2]. Participants also experienced improvements in cardiovascular risk markers including blood pressure, lipid profiles, and inflammatory markers.
Unlike earlier GLP-1 treatments, Mounjaro's dual mechanism targets both GLP-1 and GIP receptors, which may explain its superior efficacy in clinical trials. Patients typically start on a 2.5mg weekly dose, gradually titrating upward to minimise gastrointestinal side effects whilst optimising weight loss outcomes.
Wegovy and Saxenda: Established Semaglutide and Liraglutide Options
Saxenda (liraglutide) offers a daily injection alternative for patients who may benefit from more frequent dosing. Clinical trials demonstrated average weight loss of 8% over 56 weeks when combined with reduced-calorie diet and increased physical activity [4]. Saxenda's daily administration provides flexibility for some patients, though it requires more frequent injections than weekly options. Both Wegovy and Saxenda are available through Cured Pharmacy following clinical assessment by our UK prescribers, with competitive UK pricing and discreet delivery.
Wegovy (Semaglutide) Once-Weekly Injections
Wegovy contains semaglutide, a GLP-1 receptor agonist that has been extensively studied in the STEP clinical trial programme. The STEP 1 trial showed participants achieved an average weight loss of 14.9% over 68 weeks, compared to 2.4% with placebo [3]. Wegovy is administered once weekly via pre-filled pen, starting at 0.25mg and gradually increasing to a maintenance dose of 2.4mg.
Semaglutide works by slowing gastric emptying, reducing appetite, and improving glycaemic control. Common side effects include nausea, diarrhoea, and constipation, which typically diminish as your body adjusts to the medication. Wegovy is licensed for adults with a BMI of 30 or above, or 27 with at least one weight-related comorbidity.
| Treatment | Active Ingredient | Administration | Starting Price |
|---|---|---|---|
| Mounjaro | Tirzepatide | Once weekly injection | From £124.99 |
| Wegovy | Semaglutide | Once weekly injection | From £69.00 |
| Saxenda | Liraglutide | Daily injection | From £68.00 |
| Orlistat | Orlistat 120mg | Three times daily capsule | From £32.00 |
| Xenical | Orlistat 120mg | Three times daily capsule | From £32.00 |
| Wegovy Oral Tablets | Semaglutide | Daily tablet (pre-order) | From £69.00 |
Comparing Prescription Weight Loss Injections: Which Treatment Suits You?
Choosing between Mounjaro, Wegovy, and Saxenda depends on multiple factors including your medical history, weight loss goals, tolerance for side effects, and lifestyle preferences. Mounjaro's dual-agonist mechanism has demonstrated the highest average weight reduction in head-to-head comparisons, but individual responses vary significantly [2][3].
Wegovy offers robust clinical evidence with once-weekly convenience and may be preferred for patients who have previously responded well to GLP-1 treatments. Saxenda's daily dosing provides more frequent reinforcement of appetite control, which some patients find beneficial for adherence to dietary changes. Your UK prescriber will assess your BMI, weight-related health conditions, previous weight loss attempts, and any contraindications before recommending the most appropriate treatment.
Cost considerations also play a role in treatment selection. At Cured Pharmacy, we maintain transparent upfront pricing across all weight loss injections, with no hidden consultation fees. Our lowest price guarantee ensures you're accessing genuine UK-licensed medications at competitive rates, supported by our GPhC-registered clinical team throughout your treatment journey.
Oral Weight Loss Medications: Orlistat and Alternatives
Orlistat may be suitable for patients who prefer oral medication over injections, have contraindications to GLP-1 treatments, or are working toward more modest weight loss goals. At Cured Pharmacy, prescription-strength Orlistat 120mg and Xenical are available following clinical consultation, alongside lower-dose options that can be purchased with pharmacist guidance. All orlistat products require commitment to dietary modification for optimal results and to minimise side effects.
How Orlistat Works Differently from Injectable Treatments
Orlistat (available as prescription-strength 120mg Xenical or lower-dose 60mg Alli and Orlos) works through a completely different mechanism than GLP-1 injections. Rather than affecting appetite hormones, orlistat inhibits pancreatic lipase enzymes, preventing approximately 30% of dietary fat from being absorbed in the intestine [5].
Clinical trials show orlistat produces modest weight loss of 5-10% when combined with a reduced-calorie, lower-fat diet. Side effects are primarily gastrointestinal and directly related to fat intake — patients who consume high-fat meals whilst taking orlistat often experience oily stools, flatulence, and faecal urgency. These effects can be minimised by adhering to a diet containing no more than 30% of calories from fat.
Starting Your Weight Loss Treatment with Cured Pharmacy
Ongoing support is essential for successful weight management. Cured Pharmacy provides continuous access to our clinical team for questions about side effects, dose adjustments, or treatment concerns. We facilitate regular follow-up assessments to monitor your progress and ensure your treatment remains safe and effective. Weight loss injections work best when combined with sustainable dietary changes and increased physical activity — our team can provide guidance on evidence-based lifestyle modifications to optimise your results.
All pricing is transparent before you complete your consultation, with no hidden fees or surprise charges. Our lowest price guarantee means you're accessing genuine UK-licensed medications at the most competitive rates available from a registered online pharmacy. Start your free assessment today to discover which prescription weight loss treatment is right for you.
The Clinical Assessment Process
Every prescription weight loss treatment begins with a free online consultation that takes under three minutes to complete. You'll provide information about your weight, height, medical history, current medications, and previous weight loss attempts. Our UK-registered prescribers review each assessment individually, ensuring treatments are clinically appropriate and safe for your specific circumstances.
If approved, your prescription is sent electronically to our dispensary where superintendent pharmacist Tarun Kumar and our GPhC-registered team prepare your medication. We use 100% discreet packaging with next-day delivery options across the UK. Your first prescription typically includes detailed injection technique guidance, storage instructions, and information about managing potential side effects.
Scientific References
- National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. [accessed 13 August 2026]
- Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
- Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
- Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
- Sjöström, L., Rissanen, A., Andersen, T., et al. (1998). Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. The Lancet, 352(9123), 167–172. https://doi.org/10.1016/S0140-6736(97)11509-4 [accessed 13 August 2026]
- NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
- NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
- NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.
How it Works?
Select from our recommended UK-licensed medications.
1Choose your treatment

Select safe UK treatments. Quick answers.
2Answer quick questions

We will deliver direct to you as quickly as tomorrow.
3Get it delivered fast

Start Your Assessment For Weight Loss
Start your journey to better health today.
- Reviewed by UK-based prescribers
- Takes under 3 minutes
- Discreet Packaging
Start Your Journey To Better Health Today
Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.
Start My Assessment Log in to Your AccountFaq
Medically reviewed by
Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)
Reviewed on: June 03, 2026
Last updated on 13 August 2026.
Review History
Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.
Why this page was updated on 13 August 2026
Content checked and updated as part of our periodic review, to ensure accuracy and currentness.
Current version (13 August 2026)
Edited by: The Editorial Team
Medically reviewed by:
Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist
How we source info.
When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.